Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma

Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):253-256. doi: 10.1016/j.hemonc.2018.03.006. Epub 2018 Apr 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Busulfan / pharmacology
  • Busulfan / therapeutic use*
  • Cyclophosphamide / pharmacology
  • Cyclophosphamide / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous / methods*

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Busulfan